InvestorsHub Logo
Followers 93
Posts 8868
Boards Moderated 0
Alias Born 05/06/2014

Re: BesaoT35 post# 96

Tuesday, 04/14/2020 8:27:11 AM

Tuesday, April 14, 2020 8:27:11 AM

Post# of 811
You missed the $1.00 entry. It went there upon news of the Phase 3 failure of Menlo's only drug candidate. Now it's going back to at least $2.00 which is a recent analyst projection based on expected earnings of .25 on May 5 report, and the expected NDA approval in June.

There are no more failures on the horizon. Keep in mind this isn't an easily manipulated penny stock.

$1 might be a good low entry point.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News